Retraction Note: Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted antitumor drug delivery system with sequential release functions (Journal of Experimental & Clinical Cancer Research, (2015), 34, 1, (106), 10.1186/s13046-015-0216-8);Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: Promising targeted anti-tumor drug delivery system with sequential release functions

Journal of Experimental and Clinical Cancer Research

Volumn 34, Issue 1, 2015, Pages

  Fan, Li ^a   Yang, Qian ^a   Tan, Jiali ^b   Qiao, Youbei ^a   Wang, Qiaofeng ^a   He, Jingya ^a   Wu, Hong ^a   Zhang, Yongsheng ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Au nanoparticles; Chitosan; Drug delivery; Folic acid; miR 218; Temozolomide

Indexed keywords

CHITOSAN; FOLIC ACID; GOLD NANOPARTICLE; MICRORNA; MICRORNA 218; TEMOZOLOMIDE; UNCLASSIFIED DRUG; 11-MERCAPTOUNDECANOIC ACID; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DACARBAZINE; DELAYED RELEASE FORMULATION; FATTY ACID; GOLD DERIVATIVE; MACROGOL DERIVATIVE; METAL NANOPARTICLE; MIRN218 MICRORNA, HUMAN; NANOGEL; POLYETHYLENEIMINE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG SCREENING; GLIOBLASTOMA; NUDE MOUSE; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CHITOSAN; DACARBAZINE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FATTY ACIDS; FEMALE; GLIOBLASTOMA; GOLD COMPOUNDS; HUMANS; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; SULFHYDRYL COMPOUNDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84942328927     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-021-02064-9     Document Type: Erratum

References (24)

1. Cui Z, Huang L. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer. Cancer Immunol Immunother. 2005;54:1180-90.
2. Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, et al. Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res. 2014;33:29.
3. Yu DD, Wang CT, Shi HS, Li ZY, Pan L, Yuan QZ, et al. Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant. J Exp Clin Cancer Res. 2010;29:46.
4. Melucci E, Cosimelli M, Carpanese L, Pizzi G, Izzo F, Fiore F, et al. Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres. J Exp Clin Cancer Res. 2013;32:13.
5. Chen ZY, Liang K, Qiu RX. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J Exp Clin Cancer Res. 2010;29:152.
6. Zhang Y, Xiao C, Li M, Chen J, Ding J, He C, et al. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Macromol Biosci. 2013;13:584-94.
7. Hu X, Hao X, Wu Y, Zhang J, Zhang X, Wang PC, et al. Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response. J Mater Chem B Mater Biol Med. 2013;1:1109-18.
8. Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, et al. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2011;77:26-35.
9. Khan AK, Rashid R, Murtaza G, Zahra A. Gold nanoparticles: synthesis and applications in drug delivery. Trop J Pharm Res. 2014;13:1169-77.
10. Mayhew E, Juliano R. Interaction of polynucleotides with cultured mammalian cells. II. Cell surface charge density and RNA uptake. Exp Cell Res. 1973;77:409-14.
11. Bhattacharjee S, de Haan LH, Evers NM, Jiang X, Marcelis AT, Zuilhof H, et al. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol. 2010;7:25.
12. Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano. 2010;4:365-79.
13. Zhang M, Li XH, Gong YD, Zhao NM, Zhang XF. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials. 2002;23:2641-8.
14. Keong LC, Halim AS. In vitro models in biocompatibility assessment for biomedical-grade chitosan derivatives in wound management. Int J Mol Sci. 2009;10:1300-13.
15. Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004;56:1099-109.
16. Pacardo DB, Ligler FS, Gu Z. Programmable nanomedicine: synergistic and sequential drug delivery systems. Nanoscale. 2015;7:3381-91.
17. Qin LS, Jia PF, Zhang ZQ, Zhang SM. ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosis. J Exp Clin Cancer Res. 2015;34:57.
18. Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013;73:6046-55.
19. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96.
20. Yu CH, Zhu LL, Zhang RC, Wang XL, Guo CC, Sun PC, et al. Investigation on the Mechanism of the Synthesis of Gold(I) Thiolate Complexes by NMR. J Phys Chem C. 2014;118:10434-40.
21. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83-97.
22. Dube D, Francis M, Leroux JC, Winnik FM. Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Bioconjug Chem. 2002;13:685-92.
23. Zhang S, Chu Z, Yin C, Zhang C, Lin G, Li Q. Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. J Am Chem Soc. 2013;135:5709-16.
24. Gravier J, Schneider R, Frochot C, Bastogne T, Schmitt F, Didelon J, et al. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J Med Chem. 2008;51:3867-77.